Skip to main content
. 2008 Aug;4(4):743–757. doi: 10.2147/ndt.s2006

Table 4.

Experimental therapeutics of Parkinson’s disease

MAOI: Safinamide
DA: Sumanirole
DA reuptake blockers: NS 2330
Antidyskinesia drugs: Sarizotan, istradefylline (KW-6002), fipamazole (JP-1730), levetiracetam
Trophic drugs: GPI 1485, CERE-120, GDNF
Neuroprotective drugs: CoQ10, TCH 346, CEP-1347, minocycline, creatine
Surgery: fetal grafts, Spheramine®

Abbreviations: DA, dopamine agonists; MAO, monoamine oxidases.